Provided By GlobeNewswire
Last update: Sep 5, 2025
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has been elected to succeed Mr. Cuneo as Chairman of the Board, effective September 2, 2025. Mr. Cuneo will continue as a strategic advisor to the Company.
Read more at globenewswire.comNASDAQ:ECOR (10/9/2025, 12:51:30 PM)
5.28
+0.13 (+2.52%)
Find more stocks in the Stock Screener